Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39357
Title: | Big pharma’s search for a COVID-19 vaccine: Take It To The Limit! | Authors: | SEGERS, Jean-Pierre Gaile-Sarkane, Elina |
Issue Date: | 2021 | Publisher: | Source: | Journal of Innovation Management, 9 (2) , p. I -VII | Abstract: | The 2020 COVID-19 pandemic undermines the world economy, the affordability and accessibility of our health systems. It puts an increasing strain on global production, supply and value chains. The research and development of a set of COVID-19 vaccines is an unprecedented triumph of rapid innovation. The sense of urgency has prompted academic research institutions, big pharmaceuticals and dedicated biotechnology companies to develop vaccines targeting the SARS-CoV-2 coronavirus disease. Simultaneously, it unlocks new value for business, patients and society. Consequently, new business models have come to the forefront. | Keywords: | COVID-19;Vaccines;Biopharmaceutical industry;Business Models;Ecosystems | Document URI: | http://hdl.handle.net/1942/39357 | ISSN: | 2183-0606 | DOI: | 10.24840/2183-0606_009.002_0001 | Rights: | open access creative commons 3.0 | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
L1_904.pdf | Published version | 494.28 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.